136 related articles for article (PubMed ID: 20419882)
1. [Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].
Saidi Y; Guesmi F; Landolsi M; Trabelsi S; Khemiri K; Ounalli K; Dziri C; Houissa M
Tunis Med; 2010 Jan; 88(1):63-4. PubMed ID: 20419882
[No Abstract] [Full Text] [Related]
2. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Baber U; Akhter M; Kothari S; Sharma SK; Kini A
J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
[TBL] [Abstract][Full Text] [Related]
3. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
4. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
Ryding AD; Banning AP
Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
[No Abstract] [Full Text] [Related]
5. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
[TBL] [Abstract][Full Text] [Related]
6. [Drug-eluting stents can increase the risk of late stent thrombosis].
Skyttberg N; Linder R; Carlsson J
Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
[No Abstract] [Full Text] [Related]
7. Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy.
Balbi M; Fedele M; Bezante GP; Brunelli C; Barsotti A
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):839-42. PubMed ID: 20216229
[No Abstract] [Full Text] [Related]
8. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
[TBL] [Abstract][Full Text] [Related]
9. A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent.
Sharifkazemi MB; Zamirian M; Aslani A
Cardiology; 2007; 108(4):273-4. PubMed ID: 17114881
[TBL] [Abstract][Full Text] [Related]
10. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
11. Ticlopidine and aspirin therapy following implantation of coronary artery stents.
Hobson AG; Sowinski KM
Ann Pharmacother; 1997 Jun; 31(6):770-2. PubMed ID: 9184720
[TBL] [Abstract][Full Text] [Related]
12. Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days.
Xue F; Yang XJ; Cheng XJ; Hui J; Jiang TB; Chen T; Liu ZH; Song JP; Jiang WP
Chin Med J (Engl); 2009 Oct; 122(19):2394-5. PubMed ID: 20079146
[No Abstract] [Full Text] [Related]
13. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
Moussa ID; Colombo A
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
[TBL] [Abstract][Full Text] [Related]
14. [What should one pay attention to during surgery shortly after brachytherapy with coated stents?].
Schneider C
Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1586. PubMed ID: 15243911
[No Abstract] [Full Text] [Related]
15. Coronary stents and noncardiac surgery.
Riddell JW; Chiche L; Plaud B; Hamon M
Circulation; 2007 Oct; 116(16):e378-82. PubMed ID: 17938292
[No Abstract] [Full Text] [Related]
16. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
17. Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.
Campo G; Valgimigli M; Carrescia C; Carletti R; Ferrari R
Clin Appl Thromb Hemost; 2010 Oct; 16(5):591-3. PubMed ID: 19520678
[TBL] [Abstract][Full Text] [Related]
18. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén H; Agren A; Nekludov M
Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
[No Abstract] [Full Text] [Related]
19. [After coronary intervention. Which platelet inhibitor for whom?].
Stiefelhagen P
MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756
[No Abstract] [Full Text] [Related]
20. Perioperative management of the patient with a coronary stent.
Popescu WM
Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
